This site uses cookies. By using this site you agree to receiving cookies. View Policy.

126%

SleepCogni puts the power of a good night’s sleep in your hands. Using clinically tested, patented technology; combining a handheld device with a SaaS platform, users can control their wind down process by collecting physiological, behavioural & environmental data. We're fundraising to commercialise the product.

  • FDA Registered as a medical device with 11 granted patents
  • SleepCogni reduced Clinical Insomnia to Non-Clinical in just 7 days in trial
  • £1m invested including VC Mercia, £625k in R&D grants from Innovate UK
  • Medbridge Healthcare opportunity to roll out to 130 sleep clinics (subject to trial) 

Idea

Putting the power of a goodnight sleep, back in your hands
SleepCogni: a new treatment, proven to reduce insomnia in just 7 days
SleepCogni: a new treatment, proven to reduce insomnia in just 7 days
The device provides detailed and informative insights into the person’s sleep struggle
The device provides detailed and informative insights into the person’s sleep struggle

1 in 3 people experience sleep challenges at some point in their lives. Apart from medication, we feel the market offering only focuses on monitoring sleep, rather than the process of getting to sleep.

- One study suggests 38% of sufferers reported insomnia for 5+ years

- 1m people in the UK take sleeping pills for insomnia

- 70% of people have had new sleep challenges since COVID-19

SleepCogni focuses on the pathway to sleep; helping users control their wind down process with patented, award-winning technology. Our device receives data from 15 different sensors, providing detailed & informative insights into the person’s sleep struggle that are used for clinical intervention including CBT-I (cognitive behavioural therapy for insomnia). SleepCogni's haptic feedback is designed to break cognitive cycles that prevent sleep.

We'll initially target sleep clinics in the UK & US (US sleep clinic market in 2020 = $9bn). We'll then expand into other countries by also targeting health insurers. We have 11 granted & 4 pending patents in various territories, a trademark on the logo & protection of specific handheld trigger hardware.

Having found our niche in the sleep healthcare market, we're now fundraising to commercialise the product. Invest in SleepCogni and put the power of a good night’s sleep back in people's hands.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the SleepCogni pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

SleepCogni has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.